Tianjin Ringpu Bio-Technology Co.,Ltd.
XSEC:300119 Stok Raporu
Tianjin Ringpu Bio-TechnologyLtd Gelecekteki Büyüme
Future kriter kontrolleri 2/6 Tianjin Ringpu Bio-TechnologyLtd kazanç ve gelirin sırasıyla yıllık 18.3% ve 15.7% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 17.9% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 10.9% olacağı tahmin edilmektedir.
Anahtar bilgiler Pharmaceuticals kazanç büyümesi 19.4% Gelir büyüme oranı 15.7% Gelecekteki özkaynak getirisi 10.9% Analist kapsamı Good
Son güncelleme 08 Nov 2024
Gelecekteki son büyüme güncellemeleri
Tüm güncellemeleri göster
Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) announces an Equity Buyback for CNY 160 million worth of its shares. Nov 07
Investor sentiment improves as stock rises 19% Nov 06
Third quarter 2024 earnings released: EPS: CN¥0.19 (vs CN¥0.21 in 3Q 2023) Oct 30
Investor sentiment deteriorates as stock falls 16% Oct 15
Tianjin Ringpu Bio-Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 24, 2024 Sep 30
Investor sentiment improves as stock rises 18% Sep 27
Second quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.21 in 2Q 2023) Aug 24
Now 20% overvalued Jul 19
Tianjin Ringpu Bio-Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 24, 2024 Jun 29
First quarter 2024 earnings released: EPS: CN¥0.19 (vs CN¥0.17 in 1Q 2023) Apr 26
Full year 2023 earnings released: EPS: CN¥0.98 (vs CN¥0.75 in FY 2022) Mar 31 Tianjin Ringpu Bio-Technology Co.,Ltd., Annual General Meeting, Apr 19, 2024
Now 23% overvalued Mar 11
Investor sentiment improves as stock rises 16% Feb 08
Now 33% overvalued Feb 06
Tianjin Ringpu Bio-Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 30, 2024 Dec 30
Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) announces an Equity Buyback for CNY 80 million worth of its shares. Oct 29
Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) announces an Equity Buyback for CNY 80 million worth of its shares. Oct 28
Third quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.20 in 3Q 2022) Oct 26
Tianjin Ringpu Bio-Technology Co.,Ltd. to Report Q3, 2023 Results on Oct 26, 2023 Sep 30
Second quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.15 in 2Q 2022) Aug 26
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 June 2023 Jun 03
First quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.16 in 1Q 2022) Apr 28
High number of new and inexperienced directors Nov 16
Third quarter 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.22 in 3Q 2021) Oct 27
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces Executive Appointments Sep 15
Second quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.22 in 2Q 2021) Aug 26
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces Cash Dividend of A Shares for 2021, Payable on 13 June 2022 Jun 08
First quarter 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.29 in 1Q 2021) May 02
No independent directors Apr 27
Tianjin Ringpu Bio-Technology Co.,Ltd. Approves Cash Dividend for the Year 2021 Apr 20
Tianjin Ringpu Bio-Technology Co.,Ltd., Annual General Meeting, Apr 18, 2022 Mar 31
Tianjin Ringpu Bio-Technology Co.,Ltd., Annual General Meeting, Apr 18, 2022 Mar 30
Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Dividend for Year 2021 Mar 29
Full year 2021 earnings released: EPS: CN¥1.03 (vs CN¥1.01 in FY 2020) Mar 29
Third quarter 2021 earnings released: EPS CN¥0.22 (vs CN¥0.26 in 3Q 2020) Oct 28
Second quarter 2021 earnings released: EPS CN¥0.22 (vs CN¥0.19 in 2Q 2020) Aug 28
Investor sentiment deteriorated over the past week Jun 14
First quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.18 in 1Q 2020) Apr 30
Investor sentiment improved over the past week Mar 23 Tianjin Ringpu Bio-Technology Co., Ltd. Proposes Cash Dividend for the Year 2020
Tianjin Ringpu Bio-Technology Co., Ltd. announced that it expects to receive CNY 1.336 billion in funding Mar 16
Revenue misses expectations Mar 05
Full year 2020 earnings released: EPS CN¥1.01 (vs CN¥0.49 in FY 2019) Mar 04
New 90-day high: CN¥26.39 Feb 20
Investor sentiment improved over the past week Jan 28
New 90-day high: CN¥23.90 Jan 27
Tianjin Ringpu Bio-Technology Co., Ltd. to Report Fiscal Year 2020 Results on Mar 16, 2021 Jan 22
New 90-day low: CN¥18.23 Jan 11
New 90-day low: CN¥19.34 Dec 23
Third quarter earnings released Oct 29
Market bids up stock over the past week Oct 13
Earnings released Aug 27
Kazanç ve Gelir Büyüme Tahminleri XSEC:300119 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions ) Tarih Gelir Kazançlar Serbest Nakit Akışı Faaliyetlerden Nakit Avg. Analist Sayısı 12/31/2026 3,463 618 781 634 7 12/31/2025 3,073 542 118 559 8 12/31/2024 2,635 423 107 456 8 9/30/2024 2,409 424 326 537 N/A 6/30/2024 2,354 434 186 437 N/A 3/31/2024 2,339 460 196 438 N/A 12/31/2023 2,249 453 134 378 N/A 9/30/2023 2,195 387 129 386 N/A 6/30/2023 2,170 385 156 462 N/A 3/31/2023 2,136 355 139 473 N/A 1/1/2023 2,084 347 17 389 N/A 9/30/2022 1,985 354 -1 367 N/A 6/30/2022 1,875 349 0 317 N/A 3/31/2022 1,838 369 -41 287 N/A 1/1/2022 2,007 413 77 383 N/A 9/30/2021 2,038 438 72 358 N/A 6/30/2021 2,117 454 87 408 N/A 3/31/2021 2,106 441 134 438 N/A 12/31/2020 2,000 398 129 388 N/A 9/30/2020 1,895 302 175 460 N/A 6/30/2020 1,737 255 183 417 N/A 3/31/2020 1,613 224 190 396 N/A 12/31/2019 1,467 194 154 384 N/A 9/30/2019 1,346 158 83 264 N/A 6/30/2019 1,260 137 56 216 N/A 3/31/2019 1,203 124 32 167 N/A 12/31/2018 1,190 119 62 175 N/A 9/30/2018 1,179 108 40 155 N/A 6/30/2018 1,157 117 N/A 159 N/A 3/31/2018 1,112 112 N/A 113 N/A 12/31/2017 1,047 105 N/A 110 N/A 9/30/2017 1,008 136 N/A 152 N/A 6/30/2017 993 138 N/A 155 N/A 3/31/2017 988 140 N/A 185 N/A 12/31/2016 970 133 N/A 208 N/A 9/30/2016 943 129 N/A 214 N/A 6/30/2016 905 113 N/A 221 N/A 3/31/2016 832 108 N/A 223 N/A 12/31/2015 793 110 N/A 225 N/A 9/30/2015 690 68 N/A 172 N/A 6/30/2015 639 43 N/A 131 N/A 3/31/2015 625 34 N/A 140 N/A 12/31/2014 585 27 N/A 130 N/A 9/30/2014 669 95 N/A 138 N/A 6/30/2014 676 113 N/A 136 N/A 3/31/2014 722 140 N/A 116 N/A 12/31/2013 755 152 N/A 89 N/A
Daha fazla göster
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: 300119 'nin tahmini kazanç büyümesi (yıllık 18.3% ) tasarruf oranının ( 2.8% ) üzerindedir.
Kazançlar ve Piyasa: 300119 şirketinin kazançlarının (yıllık 18.3% ) CN pazarından (yıllık 26.5% ) daha yavaş büyümesi öngörülüyor.
Yüksek Büyüme Kazançları: 300119 şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde .
Gelir ve Pazar: 300119 şirketinin gelirinin (yıllık 15.7% ) CN pazarından (yıllık 14.1% ) daha hızlı büyümesi öngörülüyor.
Yüksek Büyüme Geliri: 300119 şirketinin gelirinin (yıllık 15.7% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: 300119 'nin Özsermaye Getirisi 'nin 3 yıl içinde düşük olması tahmin ediliyor ( 10.9 %).
Büyüyen şirketleri keşfedin Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}